← All trials
NCT03533556
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 14, 2018
- Primary completion
- Aug 31, 2018
- Completion date
- Dec 31, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 12
- Arms / groups
- — / —
- Source
- AACT · ingestion pipeline
Sponsors
- Texas Tech UniversityLead sponsor
- Texas Tech UniversityCollaborator
- Texas Tech UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.